NVIDIA Corporation is a leading technology company primarily known for its innovations in graphics processing units (GPUs) that enhance visual computing across various applications, including gaming, professional visualization, and artificial intelligence. Beyond its strong presence in gaming, NVIDIA's products are integral to deep learning and data center solutions, empowering advancements in machine learning, autonomous vehicles, and high-performance computing. By leveraging its cutting-edge technologies, NVIDIA aims to drive the future of computing and improve experiences across industries, from entertainment to scientific research. Read More
A number of stocks fell in the morning session after a surprisingly weak July jobs report and the announcement of sweeping new tariffs fueled fears of an economic slowdown and an impending interest rate cut.
Shares of fast food chain El Pollo Loco (NASDAQ:LOCO)
jumped 4.7% in the morning session after the fast-food chain reported strong second-quarter results that surpassed analyst expectations for both revenue and profit. The company posted revenue of $125.8 million, driven by investments in its brand and successful menu innovations like new wraps and salads. Adjusted earnings reached $0.28 per share, beating consensus estimates. El Pollo Loco also highlighted significant growth in its digital channel, which accounted for more than a quarter of all sales. This outperformance occurred while the wider restaurant industry experienced softer demand, prompting analysts to grow more bullish on the company's outlook.
Shares of biotech company Regeneron (NASDAQ:REGN)
jumped 3.3% in the morning session after the company reported strong second-quarter financial results that significantly surpassed analyst expectations. The pharmaceutical giant posted earnings per share of $12.89, which crushed the forecast of $8.50. Revenue also beat projections, totaling $3.68 billion against an expected $3.29 billion. This performance marked a notable rebound from the prior quarter. The growth stemmed from strong sales of key treatments, including its eye care therapy Eylea HD, cancer drug Libtayo, and immunology medicine Dupixent, which all recorded substantial sales increases.
Shares of financial and compliance reporting software company Workiva (NYSE:WK)
jumped 26.5% in the morning session after the company reported strong second-quarter financial results that beat Wall Street estimates and raised its full-year guidance.
Shares of modular flooring manufacturer Interface (NASDAQ:TILE) jumped 19.1% in the morning session after the company reported strong second-quarter earnings that surpassed analyst expectations and raised its full-year forecast. The carpet tile maker announced adjusted earnings of $0.60 per share on revenue of approximately $376 million, which comfortably beat Wall Street's projections. This performance represented a significant 50% jump in adjusted earnings and an 8% increase in sales compared to the same quarter last year. Following the strong results, management lifted its financial guidance for the full year. The company credited its success to its "One Interface" strategy, which helped drive market share gains and expanded its gross profit margin.
Shares of satellite communications company EchoStar (NASDAQGS:SATS) fell 16.7% in the morning session after the company reported second-quarter financial results that missed analyst expectations on both revenue and earnings. The company reported second-quarter revenue of $3.72 billion, which fell short of analyst forecasts and represented a 5.8% decline from the same period last year. EchoStar also posted a loss of $1.06 per share, missing Wall Street's expectations. This loss widened significantly from the $0.76 loss per share recorded in the prior year's quarter. The combination of missing on both revenue and earnings prompted a negative reaction from investors.
Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR)
jumped 11.9% in the morning session after the company reported strong second-quarter results that beat analyst expectations and raised its full-year financial forecast. The wellness products company announced its net sales grew 4% year-over-year to $114.8 million. Profits experienced a significant jump, as net income more than quadrupled to $5.3 million compared to the same period last year. The company's adjusted EBITDA, a key measure of profitability, also increased by 8%. Bolstered by this performance, Nature's Sunshine lifted its full-year revenue guidance to a range of $460 million to $475 million. Management credited strong sales in Japan and Central Europe, alongside accelerated growth in its digital business, for the robust quarter.
Shares of dental products company Envista Holdings (NYSE:NVST)
jumped 8.2% in the morning session after the company reported second-quarter results that surpassed analyst estimates and raised its full-year financial outlook. The company posted revenue of $682 million and adjusted earnings per share of $0.26, both of which topped Wall Street's expectations. This performance stemmed from accelerated growth across its business segments, and its Specialty Products & Technologies division showed particular strength. In light of the strong results, Envista lifted its full-year guidance for 2025. The company increased its adjusted earnings per share outlook to a range of $1.05 to $1.15 and its core sales growth forecast to between 3% and 4%.
Shares of outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR)
fell 10.9% in the morning session after the company reported disappointing second-quarter 2025 financial results, including a wider net loss and a drop in sales.
Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.1% in the afternoon session as investors reacted to its second-quarter earnings report, where a year-over-year revenue decline overshadowed beats on profit and sales forecasts. The life sciences company reported that revenue fell 3% from the prior year, sparking concerns about its growth trajectory. Management pointed to challenges in the research market, citing uncertainty around National Institutes of Health (NIH) funding and ongoing export restrictions that limited sales in China. These company-specific issues were compounded by broader market fears over new tariffs and weak U.S. jobs data. While Illumina did raise its full-year profit guidance and announced the acquisition of SomaLogic, investors focused on the top-line revenue weakness.
AI chip stocks down as Trump announces tariffs on China and Taiwan. Big tech giants investing billions in AI infrastructure, fueling next industrial revolution.
Anthropic Chief Scientist Dario Amodei has vehemently denied allegations made by Nvidia (NASDAQ: NVDA) CEO Jensen Huang that he is attempting to dominate the AI industry.
